Publications
5491 Results
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #881
- Year
- 2021
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1826
The Evolution of Children’s Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #522
- Year
- 2021
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500
Proteogenomic Characterization of Highly Enriched Viable Leukemic Blasts in Acute Myeloid Leukemia: A SWOG Report
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #799
- Year
- 2021
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500
Global Proteomic Profiling Identifies Novel Prognostic Biomarkers in Undifferentiated Leukemia Blasts from Patients with NPM1 Mutations: A First-Of-Its-Kind Report Form the Fred Hutch and SWOG
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), oral, #413
- Year
- 2021
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/E2906
Allogeneic transplantation in fit older adults is feasible and encouragingly efficacious. Post-remission data from the prospective ECOG-ACRIN (E2906) clinical study
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #1562
- Year
- 2021
- Research Committee(s)
- Leukemia
- Study Number(s)
- CTSU/E1912
Quality of Life in Patients <=70 Years of Age with Chronic Lymphocytic Leukemia Treated Frontline with Ibrutinib-Rituximab Versus Fludarabine Cyclophosphamide Rituximab: Analysis from ECOG-ACRIN E1912
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #3457
- Year
- 2021
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106
Duplex Sequencing for Ultra-Low Frequency Measurable Residual Disease Detection in Adult Acute Myeloid Leukemia
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #3397
- Year
- 2021
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1318
A Phase 2 Study of Dasatinib, Prednisone, and Blinatumomab for Elderly Patients with Philadelphia-Chromosome (Ph) Positive or Ph-Like Acute Lymphoblastic leukemia (ALL) (with Dasatinib Sensitive Fusions/ Mutations)
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), spotlight poster discussion, abst 415; PD5-04
- Year
- 2021
- Research Committee(s)
- Breast
Risk factors for long-term adjuvant chemotherapy toxicity using pre-treatment host factors and self-rated treatment bother (GP5) in a clinical trial population
- Journal / Conference
- San Antonio Breast Cancer Symposium (Dec 7-10, 2021, San Antonio, TX), poster, #P4-10-02
- Year
- 2021
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/EA1131
Patient-Reported Outcomes in ECOG-ACRIN EA1131: A randomized phase III trial of platinum vs. capecitabine in patients with residual triple-negative breast cancer after neoadjuvant chemotherapy
- Journal / Conference
- ASCO Plenary Series, November 16, 2021, oral
- Year
- 2021
- Research Committee(s)
- Melanoma
- Study Number(s)
- CTSU/EA6134